KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Accounts Payables: 2010-2024

Historic Accounts Payables for Dynavax Technologies (DVAX) over the last 15 years, with Dec 2024 value amounting to $9.1 million.

  • Dynavax Technologies' Accounts Payables fell 44.31% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 44.31%. This contributed to the annual value of $9.1 million for FY2024, which is 72.76% up from last year.
  • Dynavax Technologies' Accounts Payables amounted to $9.1 million in FY2024, which was up 72.76% from $5.2 million recorded in FY2023.
  • Dynavax Technologies' Accounts Payables' 5-year high stood at $9.1 million during FY2024, with a 5-year trough of $2.6 million in FY2021.
  • In the last 3 years, Dynavax Technologies' Accounts Payables had a median value of $5.2 million in 2023 and averaged $5.8 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first tumbled by 64.30% in 2020, then spiked by 72.76% in 2024.
  • Dynavax Technologies' Accounts Payables (Yearly) stood at $3.3 million in 2020, then fell by 21.50% to $2.6 million in 2021, then rose by 23.50% to $3.2 million in 2022, then skyrocketed by 63.34% to $5.2 million in 2023, then soared by 72.76% to $9.1 million in 2024.